Late Detection of Critical Congenital Heart Disease Among US Infants
Cora Peterson(National Center on Birth Defects and Developmental Disabilities), Suzanne M. Gilboa(Centers for Disease Control and Prevention), Gary M. Shaw(Stanford University), Tiffany Riehle‐Colarusso(Centers for Disease Control and Prevention), Matthew E. Oster(Children's Healthcare of Atlanta), Cynthia H. Cassell(Centers for Disease Control and Prevention), David E. Fixler(Northwestern Memorial Hospital), Suzan L. Carmichael(Stanford Medicine), Richard S. Olney(University of Iowa), Elizabeth C. Ailes(Centers for Disease Control and Prevention)
Cited by 130
Related Papers
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
Temporal and spatial variation of the human microbiota during pregnancy
|Proceedings of the National Academy of Sciences|2015|1.2k
Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021
|JAMA|2022|670
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices — United States, June 2021
|MMWR Morbidity and Mortality Weekly Report|2021|602
Guidelines for case classification for the national birth defects prevention study
|Birth Defects Research Part A Clinical and Molecular Teratology|2003|582